SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395401.
  • 2
    La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81: 626.
  • 3
    Coleman MP, Estève J, Damiecki P, Arslan A, Renard H. Melanoma of skin. Trends in cancer incidence and mortality. vol. 121. Lyon: IARC, 1993. 379410.
  • 4
    Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340: 13418.
  • 5
    IARC, WHO. Solar and ultraviolet radiation. Lyon: IARC, 1992.
  • 6
    Kricker A, Armstrong BK, Jones ME, Burton RC. Health, solar UV radiation and environmental change. Lyon: IARC, 1993.
  • 7
    Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 6982.
  • 8
    Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73: 198203.
  • 9
    Tersmette AC, Coebergh JW, Casparie-van Velsen IJ, Ruiter DJ, van der Rhee HJ, Welvaart K. Invasive cutaneous melanoma in the Netherlands, 1989–1990. Eur J Cancer Prev 1996; 5: 6974.
  • 10
    Armstrong BK. Descriptive epidemiology of skin cancers. In: GrobJJ, SternRS, MacKieRM, WeinstockWA, eds. Epidemiology, causes and prevention of skin diseases. Oxford: Blackwell Science, 1997. 417.
  • 11
    van der Spek-Keijser LM, van der Rhee HJ, Toth G, Van Westering R, Bruijn JA, Coebergh JW. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 1997; 136: 56571.
  • 12
    Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993. Int J Epidemiol 2000; 29: 41623.
  • 13
    Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000; 82: 188791.
  • 14
    Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst 2000; 92: 8118.
  • 15
    Dennis LK, White E, Lee JA. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 1993; 4: 93100.
  • 16
    Eurocim version 4.0. European incidence database V2.3, ICD-10 dictionary (2001). Lyon: European Network of Cancer Registries, 2001.
  • 17
    ParkinD, WhelanS, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in 5 continents. IARC Scientific Publication 143, vol. VII. Lyon: IARC, 1997.
  • 18
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 33551.
  • 19
    Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 1987; 6: 44967.
  • 20
    Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987; 6: 46981.
  • 21
    Bentham G, Aase A. Incidence of malignant melanoma of the skin in Norway, 1955–1989: associations with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol 1996; 25: 11328.
  • 22
    Mansson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976–1994. Acta Oncol 2002; 41: 13846.
  • 23
    MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, Doherty V, Vestey J. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360: 58791.
  • 24
    Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, Bart RS. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001; 44: 83746.
  • 25
    Wagener DK. Patterns of melanoma deaths in the United States. Ann NY Acad Sci 1990; 609: 2526.
  • 26
    Aase A, Bentham G. Gender, geography and socio-economic status in the diffusion of malignant melanoma risk. Soc Sci Med 1996; 42: 162137.
  • 27
    Health Council of the Netherlands, Committee on Risks of UV Radiation. UV radiation from sunlight. Amsterdam: Health Council of the Netherlands, 1994.
  • 28
    Coebergh JW, Van Leer EM, Alers JC, De Gruijl FR, Van der Kluijt-Dijken CAL, Van der Rhee HJ, De Rooij MJM, De Vries E. Ultraviolette straling en huidkanker. Amsterdam: Nederlandse Kankerbestrijding/Koningin Wilhelmina Fonds, 2002.
  • 29
    Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 Surveillance, Epidemiology, and End Results program registry. Arch Dermatol 1999; 135: 27580.
  • 30
    Rhee van der HJ, van der Spek-Keijser LM, van Westering R, Coebergh JW. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980–95. Br J Dermatol 1999; 140: 4637.
  • 31
    Northern and Yorkshire Cancer Registry and Information Service. Registration of skin cancer in Yorkshire. A study into the completeness and validity of cancer registry data. Leeds: NYCRIS, 2001.
  • 32
    van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, Briggs J, Cooke RA, Dempster AG, Essex WB. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 4839.
  • 33
    Stang A, Stang K, Stegmaier C, Hakulinen T, Jockel KH. Skin melanoma in Saarland: incidence, survival and mortality 1970–1996. Eur J Cancer Prev 2001; 10: 40715.
  • 34
    Smith JAE, Whatley PM, Redburn JC, Group EW. Improving survival of melanoma patients in Europe since 1978. Eur J Cancer 1998; 34: 2197203.
  • 35
    Kolmel KF, Kulle B, Lippold A, Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972–1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer 2002; 38: 138894.
  • 36
    Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Trends in tumour characteristics and survival of malignant melanoma 1960–84: a population-based study in Sweden. Br J Cancer 1994; 70: 7438.
  • 37
    CoeberghJWW, Janssen-HeijenenMLG, LouwmanWJ, VoogdAC (eds.). Comprehensive Cancer Centre South. Cancer incidence and survival in the south of the Netherlands, 1955–1999 and incidence in the north of Belgium, 1996–1998. Eindhoven: Comprehensive Cancer Centre South, 2001.
  • 38
    Drzewiecki KT, Frydman H, Andersen K, Poulsen H, Ladefoged C, Vibe P. Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982. Cancer 1990; 65: 3626.
  • 39
    Brochez L, Verhaeghe E, Sales F, Del Marmol V, Deraemaecker R, Vossaert K, Naeyaert JM. Current guidelines in melanoma treatment. Melanoma Working Group of Gent and Bordet. Dermatology 2000; 200: 1606.
  • 40
    Bulliard JL. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer 2000; 85: 62732.
  • 41
    Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, Peters A, Rassner G, et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995; 10: 24928.
  • 42
    Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 362234.
  • 43
    Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995; 24: 897907.
  • 44
    Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 7619.
  • 45
    Møller B, Fekjær H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T. Prediction of cancer incidence in the Nordic countries up to the year 2020. Melanoma of skin. Eur J Cancer Prev 2002;( Suppl 1): s5860.
  • 46
    Williams HC, Smith D, du Vivier AW. Evaluation of public education campaigns in cutaneous melanoma: the King's College Hospital experience. Br J Dermatol 1990; 123: 8592.
  • 47
    Melia J, Pendry L, Eiser JR, Harland C, Moss S. Evaluation of primary prevention initiatives for skin cancer: a review from a UK perspective. Br J Dermatol 2000; 143: 7018.
  • 48
    Bulliard JL, Raymond L, Levi F, Schuler G, Enderlin F, Pellaux S, Torhorst J. Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Sante Publique 1992; 40: 4318.
  • 49
    Koh HK, Geller AC. Melanoma and skin cancer control: an international perspective. Cancer Control 1995; 2: 38591.
  • 50
    Holman CD, Armstrong BK, Heenan PJ. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71: 6516.